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Yin Yang 1 is a human transcription factor that controls 
a number of genes and takes part in the regulation of 
cell cycle, proliferation, differentiation, and neuronal de-
velopment. Yin Yang 1 is composed of an N-terminal in-
trinsically disordered fragment and a C-terminal domain 
responsible for binding to DNA, composed of four zinc 
fingers. Recently, various alterations in the Yin Yang 1’s 
DNA binding domain were linked with an unexplained 
intellectual disability named Gabriele-de Vries syndrome. 
In this paper, a repetitively occurring substitution of as-
partate-380 for tyrosine was analyzed to assess its im-
pact on Yin Yang 1’s structure and DNA binding. The 
substitution was found to affect Yin Yang 1’s secondary 
and tertiary structure to a limited extent and to impair 
the specificity of its interaction with DNA.
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INTRODUCTION
Yin Yang 1 (YY1) is a ubiquitously expressed human 
transcription factor that can act as a transcription initia-
tor, activator or repressor. YY1 is crucial for cell cycle 
control, proliferation, differentiation, and neuronal devel-
opment (Gordon et al., 2006; He & Casaccia-Bonnefil, 
2008). Deletion of both yy1 alleles is lethal at the early 
stages of embryo development, while yy1+/- heterozy-
gotes exhibit neurological defects and growth retarda-
tion, which was shown in Mus musculus and Xenopus laevis 
(Donohoe et al., 1999; Morgan et al., 2004). Structur-
ally, YY1 is composed of two parts, differing in both 
structure and function. The N-terminal fragment is in-
trinsically disordered (Gorecki et al., 2015) and fulfills a 
regulatory role through a number of protein-protein in-
teractions. On the other hand, the C-terminal fragment 
of YY1 forms its DNA-binding domain (DBD) that in-
cludes four consecutive zinc fingers of C2H2 type (Hou-
baviy et al., 1996).
Pathogenic effects of substituting YY1 aspartate-380 
for tyrosine was recently reported twice, in two differ-
ent exome-sequencing studies on individuals with unex-
plained intellectual disabilities (Vissers et al., 2010; Gabri-
ele et al., 2017). One of the studies was aimed at muta-
tions in yy1 locus and in fact found several substitutions 
and deletions within the DBD (Gabriele et al., 2017). 
The finders hypothesized that the common effect of the 
discovered mutations could result from impaired DNA 
binding by the YY1 mutants. Aspartate-380 is located in 
the linker region that connects 3rd and 4th zinc fingers 
of YY1 (Fig. 1). No direct contact between aspartate-380 
and DNA was observed in the crystal structure of YY1 
nucleoprotein (Houbaviy et al., 1996). However, molecu-
lar simulations predict that D380Y substitution disrupts 
the network of hydrogen bonds on the surface of the 
YY1 molecule (Gabriele et al., 2017). Moreover, YY1 
D380Y exhibited compromised performance in chroma-
tin immunoprecipitation (Gabriele et al., 2017).
Our research group established a protocol for robust 
production of active, recombinant YY1 protein (Gole-
biowski et al., 2011) as well as a sensitive, quantitative 
equilibrium assay for YY1-DNA interaction (Golebio-
wski et al., 2012). These methods previously allowed us 
to precisely analyze the effect of another YY1 mutation, 
T372R, which is recurrent in insulinomas, and proved 
it to affect YY1 binding to DNA in a sequence-specific 
way (Nieborak & Gorecki, 2016). In this paper, we ana-
lyzed the impact of D380Y mutation on YY1 structure 
and its interaction with DNA.
MATERIALS AND METHODS
Plasmids. pET-21a/DBD — expression vector (No-
vagen) with cDNA of the DNA-binding domain of hu-
Figure 1. The amino acid sequence of the DNA-binding domain 
of human YY1 (DBD). 
The site of the pathogenic mutation is marked red. Blue and or-
ange boxes depict residues that interact with the phosphate back-
bone and nucleobases, respectively, in the co-crystal structure of 
DBD and AAV P5 initiator (Houbaviy et al., 1996). ZF1-4 denotes 
the four zinc fingers of YY1. α and β denote particular secondary 
structures.
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man YY1 (residues 295-414) cloned under the control of 
T7lac promoter, preceded by MAS sequence encoded by 
the vector. 
Bacterial strains. E. coli DH5α (Invitrogen) – used in 
cloning and for plasmid amplification; E. coli BL21(DE3) 
(Invitrogen) – used for protein expression. 
Oligonucleotide duplexes containing the DNA se-
quences specifically recognized by YY1 protein were 
5’-labeled with carboxy-x-rhodamine (ROX) on the 
antisense strand. The following sense sequences were 
analyzed: immunoglobulin heavy chain enhancer (IgH): 
5’-TGATCGGCCATCTTGACTCC-3’; adeno-associ-
ated virus P5 promoter (AAV-60): 5’-TTTTGCGA-
CATTTTGCGACA-3’; adeno-associated virus P5 initia-
tor (AAV+1): 5’-AGGGTCTCCATTTTGAAGCG-3’. 
Site-directed mutagenesis. pET21a/DBD vec-
tor was subjected to mutagenesis with the use of the 
QuikChange protocol (Stratagene). The sequences of the 
mutagenic forward and reverse primers were: GTGC-
GAATCCATACCGGATACAGGCCCTATGTGTGC 
and GCACACATAGGGCCTGTATCCGGTATGGAT-
TCGCAC, respectively. The obtained construct was se-
quenced to confirm the presence of the substitution.
Protein expression and purification. The plasmids 
encoding wild-type DBD and its D380Y variant were 
transformed into the E. coli strain BL21(DE3) (Novagen) 
which were grown on the Luria-Bertani (LB) agar plates 
with ampicillin (100 μg/mL) over night at 37°C. LB-
ampicillin medium (50 mL) was inocu lated with a single 
colony from the plate and grown overnight at 180 rpm 
shaking at 37°C. The precultures were added to 1.5 L of 
LB-ampicillin and grown at 180 rpm shaking at 37°C. 
The expression was induced at an O.D. 600 of 0.6–1.0 
with 1 mM isopropyl β-d-1-thiogalactopyranoside for 
three hours. At the time of induction, ZnCl2 was added 
to the cultures to the final concentration of 0.1 mM. 
The cells were harvest ed by centrifugation at 7 000 × g 
for 15 min at 4°C, pel leted and stored frozen at –20°C.
The bacterial pellet from the 2 L culture was resus-
pended in 30 mL of buffer A (25 mM Tris-HCl, pH 7.9, 
100 mM NaCl, 6 M guanidine hydrochloride, 1 mM phe-
nylmethylsulfonyl fluoride, 2 mM β-mercaptoethanol). 
The sus pension was sonicated for six 45-s bursts on 
ice. The lysate was cleared by centrifugation (30 000 × g, 
30 min, 4C), and the superna tant was loaded onto a 30-
mL nickel-nitrilotriacetic acid gravity-flow column (Nova-
gen) which was previously equilibrated in buffer A. The 
column was washed with 3 col umn volumes of buffer 
A. Proteins were then eluted in buffer A with addition 
of 300 mM imidazole. 1.0-mL fractions were harvest ed. 
The protein concentration was determined in triplicates 
with the Bradford assay (Bradford, 1976), calibrated with 
bovine serum albumin (BSA) (Sigma-Al drich). The pu-
rification process was monitored by so dium dodecyl 
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) 
(Laemmli, 1970) in 15% gel. Fractions containing DBD 
or its D380Y variant were pooled and reduced by a 30-
min incubation at 60°C with the addition of 10 mM eth-
ylenediamine tetraacetic acid and 100 mM dithiothreitol 
(DTT). The proteins were refolded by a three-step di-
alysis at 4°C against buffer B (25 mM Tris-HCl, pH 7.9, 
100 mM NaCl, 10 mM MgCl2, 0.1 mM ZnCl2, 5 mM 
DTT) at 1:100 ratio. The final purification step was con-
ducted using ÄKTA Explorer system (Amersham Phar-
macia Biotech) on agarose resin with immobilized oli-
gos of IgH promoter sequence, as described previously 
(Golebiowski et al., 2011). Briefly, the dialyzed samples 
were loaded onto the column and the specifically bound 
protein was eluted in the 10–100% gradient of buffers 
A1 (25 mM Tris-HCl, pH 7.9, 10 mM MgCl2, 0.1 mM 
ZnCl2, 2 mM DTT) and A2 (25 mM Tris-HCl, pH 7.9, 
1 M NaCl, 10 mM MgCl2, 0.1 mM ZnCl2, 1 mM DTT). 
Protein content and purity in the collected fractions were 
analyzed with the use of SDS-PAGE. Selected fractions 
were pooled and dialyzed at 4°C against 500-fold excess 
of buffer C (25 mM Tris-HCl, pH 7.9, 100 mM NaCl, 
10 mM MgCl2, 0.1 mM ZnCl2, 5 mM DTT), in which all 
the further analyses were performed.
Size-exclusion chromatography. Size exclusion ex-
periments were performed using ÄKTA Explorer sys-
tem (Amersham Pharmacia Biotech) on Superdex 200 
Increase 10/300 column (GE). The separations were 
monitored by absorbance measurements at 220 nm and 
280 nm to determine the elution volumes of DBD pro-
tein variants. The Stokes radii were calculated based on a 
calibration curve obtained for dextran blue and a set of 
standard proteins: thyroglobulin, apoferritin, BSA, myo-
globin, cytochrome c.
Spectroscopic measurements. Circular dichroism 
(CD) measure ments were conducted using a J-710 spec-
tropolarimeter (Jasco) equipped with an F25 temperature 
control unit (Julabo) in quartz cuvettes of 0.1 mm path-
length (Hell ma). The spectra were recorded in the range 
of 194–250 nm with 1 nm data pitch, 10 nm/min scan-
ning speed, 8 s integrating time, and 2 nm bandwidth 
and averaged over three acquisitions. The protein con-
centration was 1.1 mg/ml and 1.3 mg/ml for wild-type 
and D380Y, respectively. All spectra were corrected for 
the effect from the buffer and all measurements were 
converted to molar residual ellipticity units. Secondary 
structure content was determined using SELCON3 pro-
gram from CDPro package (Sreerama & Woody, 2000).
Fluorescence anisotropy was measured using spec-
trofluorimeter Fluorolog-3 equipped with an F25 tem-
perature control unit (Julabo). The measurements were 
conducted in a thermostated cuvette 3 × 3 mm (Hellma) 
at 25°C, with 490 nm excitation, 525 nm emission, 0.1 
s in tegration time, 8 nm and 7 nm slit widths on exci-
tation and emission monochromators, respectively, and 
averaged over three acquisitions. The samples contained 
0–38 μM DBD D380Y, in twofold serial dilutions, 50 
nM ROX-labeled DNA, 25 mM Tris-HCl, pH 7.9, 50 
mM NaCl, 10 mM MgCl2, 0.1 mM ZnCl2, 5 mM DTT, 
0.1 mg/ml BSA, 0.04% (w/v) polyethylene glycol. The 
samples were incubated on ice for 1 h and then equili-
brated at 25°C for 10 min just prior to the measurement.
RESULTS
To study the prospective changes in YY1’s structure 
and function upon D380Y substitution, we produced a 
recombinant protein carrying the mutation. The DNA-
binding domain of YY1 (DBD) was used, as the frag-
ment is solely responsible for DNA binding (Figiel & 
Gorecki, 2017). Standard protocols were used for the ex-
pression and purification, that previously had been opti-
mized for the wild-type DBD (Golebiowski et al., 2011). 
Notably, the final purification step employed an affinity 
column with immobilized DNA of sequence recognized 
by wild-type YY1. If the D380Y variant did not specifi-
cally bind DNA, this could reduce the purification yield, 
though the mutant protein could still non-specifically 
bind to the column through electrostatic interactions. 
No such reduction was in fact observed; the procedure 
was repeated twice and no significant difference in the 
production yield was observed between the D380Y mu-
tant and the wild-type DBD1.
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Structure analysis
The analyzed substitution completely changed the 
character of the side chain, replacing a charged aspartate 
moiety with the aromatic ring of tyrosine. Changing the 
protein charge, hydrophobicity and possibly the network 
of hydrogen bonds on its surface could severely disturb 
the spatial structure. To check this, we compared the 
secondary and tertiary structures of the wild-type DBD 
and its D380Y mutant.
Secondary structure content was assessed with the use 
of CD measurements in the far-UV range. The spec-
tra obtained for the two protein variants had roughly 
similar shapes but differed regarding the intensity of a 
broad negative band centered at about 215 nm (Fig. 2). 
However, deconvolution of the spectra yielded a simi-
lar content of particular secondary structure types in the 
wild-type protein and the D380Y mutant (Table 1), sug-
gesting that the propensity to fold into zinc finger mo-
tifs was retained in the mutant protein. D380 residue is 
located in the linker region between the third and fourth 
zinc fingers. Although the region had no regular arrange-
ment in the crystal structure (Houbaviy et al., 1996), the 
mutation could possibly impair the proper folding of 
both zinc fingers. Yet the amount of particular second-
ary structures differed only to a small extent between the 
wild-type and D380Y DBD. Possibly, the mutation af-
fected the distribution of conformations available for the 
protein.
Next, we analyzed the impact of D380Y mutation 
on the overall tertiary structure of DBD. Size exclu-
sion chromatography separations allowed us to com-
pare the compactness of conformation of wild-type and 
D380Y DBD variants. Substituting tyrosine for aspartate 
changed the protein’s charge and hydropathy, the two 
properties that determine the propensity of the ordered 
protein structure (Campen et al., 2008). Wild-type DBD 
has a compact, ordered structure (Gorecki et al., 2015). 
The compactness of the D380Y mutant was loosened 
compared to the wild-type protein, as demonstrated by 
its increased Stokes shift and a higher ratio of apparent 
and formula molecular masses, presented in Table 2.
DBD1 D380Y binding to DNA
Protein-DNA interaction can be affected by mutations 
in many different ways. The number of contacts can be 
decreased by substitutions of either positively charged 
residues that electrostatically interact with the phosphate 
backbone or residues that make base-specific contacts 
in the grooves of DNA helix. The preferred consensus 
sequence may also be changed. Such an effect was ob-
served for T372R mutation of YY1, which is recurrent 
in insulinomas. The 1st and 4th zinc fingers of YY1 par-
ticipate in DNA binding to a different extent in the wild 
type protein and in the T372R mutant (Cromer et al., 
2015). Similarly, the D380Y mutation might also affect 
the concerted DNA binding by YY1’s 3rd and 4th zinc 
finger, as it changes the sequence of their linker into a 
non-optimal one. In order to capture such subtle differ-
ences, we measured the affinity of DBD1 D380Y for 
three different sequences, derived from promoters actu-
ally bound by YY1, but characterized by a varying simi-
larity to the YY1 consensus motif: the immunoglobulin 
heavy chain enhancer, the adeno-associated virus P5 pro-
moter and the adeno-associated virus P5 initiator.
Fluorescence anisotropy measurements demonstrated 
that DBD1 D380Y bound DNA weaker than the wild-
type protein (Fig. 3). The affinity for IgH sequence 
was decreased the most. As a result, the binding con-
stants (presented in Table 3) were similar for all three 
sequences, even though the values differed for the wild 
type protein. Thus, we observed no differences in the 
affinity of the mutated protein for the tested sequences, 
although such a difference was clearly visible in the wild-
type protein (Golebiowski et al., 2012).
DISCUSSION
The aim of this work was to evaluate how YY1 pro-
tein’s structure and its interaction with DNA is affected 
Figure 2. Far-UV CD spectra of wild-type (WT) and D380Y DBD.
Table 1. Secondary structure content of the wild-type and D380Y 
DBD protein inferred from their CD spectra (Fig. 2). Values de-







Table 2. Hydrodynamic parameters of the wild-type and D380Y 
DBD protein obtained from size exclusion chromatography sep-
arations. The presented values are means ± S.D. of three inde-
pendent separations.
Wild-type D380Y
Apparent molecular mass [kDa] 15.1±1.7 18.7±1.0
Apparent-to-formula molecular mass 1.07 1.33
Stokes radius [Å] 18.5±1.3 21.0±0.6
Table 3. Dissociation constants for the interaction between DBD 
and DNA, obtained from fluorescence anisotropy measurements. 
The relative affinity is the ratio of association constants for the 
mutant protein vs. the wild-type.




IGH 0.21 ± 0.02 7.8 ± 0.8 37
AAV+1 0.87 ± 0.08 7.3 ± 4.8 8
AAV-60 1.22 ± 0.33 8.7 ± 3.0 7
*Data obtained by Golebiowski and others (Golebiowski et al., 2012)
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by D380Y substitution that was discovered in two cases 
of unexplained mental retardation. Aspartate-380 locates 
within the linker that connects the third and fourth zinc 
fingers of YY1 (Houbaviy et al., 1996). Linkers between 
the consecutive zinc fingers are important structural ele-
ments for protein-DNA interactions. They exhibit a con-
sensus sequence GEK and a similar spatial arrangement 
within the molecules of various proteins (Wolfe et al., 
2000). Deviations from the consensus impede the con-
certed binding of the linked zinc fingers to DNA. For 
instance, the linker between the first and second zinc 
fingers of YY1 is shorter than the consensus, impeding 
the interaction between the first zinc finger and DNA 
(Figiel & Gorecki, 2017; Chen et al., 2019).
 Aspartate-380 is located at the 3rd position of the 
linker. Although it is not the optimal glutamate residue, 
its side chain has a very similar chemical character. On 
the contrary, D380Y substitution changes the proper-
ties completely, influencing both the hydropathy and the 
charge, and possibly also introducing steric hindrance. 
Based on the molecular simulations, D380Y substitution 
is expected to disrupt the network of hydrogen bonds 
and salt bridges on the YY1-DNA interface (Gabriele 
et al., 2017). Our observations confirmed that the sub-
stitution affects YY1’s structure and its interaction with 
DNA.
The CD spectra registered in the far-UV range dif-
fered between the two variants but still allowed us to 
infer that the native secondary structure was retained 
in the D380Y mutant. Size exclusion chromatography 
separations indicated that the overall compactness of the 
protein molecule was slightly affected by D380Y substi-
tution, as it affected both the charge and the hydropa-
thy of the protein. Moreover, the mutation compromised 
YY1’s affinity to DNA and reduced its specificity. D380 
locates in a region that is important for the interaction, 
as it links the two zinc fingers that make the majority 
of specific contacts with the nucleobases (Houbaviy et 
al., 1996) (Fig. 1) and contribute the most to YY1-DNA 
binding (Chen et al., 2019).
Interestingly, the changes in fluorescence anisotropy 
of the DNA-bound ROX were more pronounced upon 
binding of DBD1 D380Y than of the wild-type protein. 
This could be explained by several mechanisms; firstly, 
the mutant protein could be unstable and more prone 
to aggregation than the wild-type protein, though the 
hydrodynamic parameters did not confirm this. Alterna-
tively, the mutant protein binding could engage the first 
zinc finger to a greater extent, decreasing the mobility of 
the dye, which is attached to the 5’ end of the reverse 
DNA strand. Such an effect was previously ascribed to 
YY1 T372R mutant (Cromer et al., 2015). Finally, YY1 
could electrostatically interact with the fluorescent dye 
attached to DNA duplex within the nucleoprotein, alter-
ing its fluorescence parameters. Such interaction could 
be abolished by D380Y substitution, as described else-
where for TraI36 mutants, E187A and R150A (Ander-
son et al., 2008).
One of the premises for investigation of YY1 D380Y 
variant was its impaired chromatin immunoprecipitation, 
previously reported by Gabriele and others (Gabriele et 
al., 2017). Apart from a compromised affinity for DNA, 
this could also be caused by abnormal interaction with 
trans regulators. This is in line with the finding of Ga-
briele and others (Gabriele et al., 2017) that the peaks re-
tained in YY1 D380Y immunoprecipitates were enriched 
in COREST, p300, PAX5 and HDAC1 motifs, com-
pared to those present only in wild-type YY1 immuno-
precipitates. In fact, D380 is located in a region involved 
in many protein-protein interactions, i.e. with E1A (Lew-
is et al., 1995), ATF2a (Zhou et al., 1995), SAP30 (Huang 
et al., 2003), or p53 (Sui et al., 2004).
The presented study was limited to an in vitro ap-
proach. An in vivo analysis would give a fuller insight 
into the malfunctions caused by the D380Y substitution. 
However, it would not allow for separate analyses of 
particular structural aspects and interactions. The simpli-
fied model enabled a detailed, quantitative analysis and 
allowed us to draw unequivocal conclusions regarding 
the character of changes in YY1 interaction with DNA. 
Functional studies on cells should be the next step to 
comprehend a full picture of the effects of D380Y mu-
tation and fill the gap between the case-control study of 
Gabriele and others (Gabriele et al., 2017) and the pre-
sented in vitro study of the underlying mechanisms.
To conclude, D380Y substitution was independently 
suggested as the cause of unexplained mental retarda-
tion twice (Vissers et al., 2010; Gabriele et al., 2017). We 
Figure 3. The binding curves obtained from the fluorescence 
anisotropy measurements for the DBD D380Y variant and three 
different promoter sequences.
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found that the substitution affected YY1’s secondary and 
tertiary structure only to a limited extent, yet it impaired 
DNA binding and decreased its specificity.
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